SciSight Ecosystem
WoS SCIE Q2Scopus Q1SCImago #3,550CAS 2区Top JournalGold OA

Orphanet Journal of Rare Diseases

Abbreviation (ISO):ORPHANET J RARE DIS
Country: England•WoS SCIE Quartile: Q2•Scopus SJR: 1.218•SCImago Rank: #3,550•Identifier (ISSN):1750-1172(Print)•Articles / Year: 474•Estimated Publication Fee (APC): $3,432 USD
Clarivate IF (2026)Q2
3.6
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
87

87 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate5.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
474articles/year
100% Gold OA•83.22% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 3.6)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.6)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.5)
🔵 Computed
20241.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.4)
🔵 Computed
20231.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.7)
🔵 Computed
20221.75đ
WoS Q2 có IF ≥ 2.0(IF: 4.303)
🔵 Computed
20211.75đ
WoS Q2 có IF ≥ 2.0(IF: 4.123)
🔵 Computed
20201.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.523)
🔵 Computed
20191.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.687)
🔵 Computed
20181.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.607)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicinePathologyGeneticsChemistryBiochemistryPsychologyPathology & DiseasesSurgeryPsychiatryEndocrinologyMathematicsSociology

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,550Scopus Q1SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.218

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
150

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
3.51

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,432 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations5,216
3-Year Documents1,304
Citable Documents1,255

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate55.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Pharmacology (medical)Q1
Genetics (clinical)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区GENETICS & HEREDITY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
BioMed Central
Publication Language
English
Frequency
Irregular
Founding Year
2006
Editorial Address
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
Indexing & Databases
SCIEScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
GENETICS & HEREDITY
JCRSCIE
61/192Q2
MEDICINE, RESEARCH & EXPERIMENTAL
JCRSCIE
79/191Q2
GENETICS & HEREDITY
JCISCIE
76/192Q2
MEDICINE, RESEARCH & EXPERIMENTAL
JCISCIE
69/191Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—432118
20253.56631,808
20243.44963,351
20233.73955,147
20224.3034538,721
20214.12352412,413
20203.52335211,609
20193.68730011,492
20183.60723110,304
2017—18912,010
2016—1698,977
2015—31511,136
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Orphanet Journal of Rare Diseases

WoS Q2
2345201820192020202120222023202420253.50
Annual Impact Factor Metric
2025:3.5

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 33797374-32df-4185-96e5-d4b0797396dc
Database Updated: 2026-09-28